DIABETES MONITORING AND CONTROL TECHNOLOGY

VolverGo back

Resultados 131 results. LastUpdate Updated on 17/01/2022 [09:47:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Page1/6 nextPage   results/page


Infusion Devices and Methods

Publication No.: US2022013224A1 13/01/2022

Applicant:

ABBOTT DIABETES CARE INC [US]

US_2021398663_A1

Absstract of: US2022013224A1

Medical devices, systems, and methods related thereto a glucose monitoring system having a first display unit in data communication with a skin-mounted assembly, the skin-mounted assembly including an in vivo sensor and a transmitter. The first display unit and a second display unit are in data communication with a data management system. The first display unit comprises memory that grants a first user first access level rights and the second display unit comprises memory that grants a second individual second access level rights.

traducir

Portable Device and Method for Non-Invasive Blood Glucose Level Estimation

Publication No.: US2022007975A1 13/01/2022

Applicant:

UNIV SEVILLA [ES]

CN_113692530_A

Absstract of: US2022007975A1

The invention relates to a device (1) comprising a measuring unit (2) with a measuring module (4) for measuring the glucose level, a first computer module (5) for processing data from a first part of the process for measuring the glucose level, a first communications module (6), a first data storage module (7) and a pushbutton (8). The device also comprises a personal monitoring unit (3) with second and third communication modules (17, 20), a second computer module (18) for processing data from a second part of the process for measuring the glucose level, an interface module (19) and a second data storage module (22). Also described is a method for non-invasive blood glucose level estimation.

traducir

NON-INVASIVE MONITORING SYSTEM

Publication No.: US2022007972A1 13/01/2022

Applicant:

AERBETIC INC [US]

AU_2019380538_A1

Absstract of: US2022007972A1

A wearable device for non-invasive monitoring of the presence, amount, and/or concentration of an analyte in a sample from a user of the device is described. The analyte is selected to be indicative of or related to a physiological status of a user. Relevant physiological status include hypoglycemia, infection, respiratory infection, urinary infection, gastrointestinal infection, obesity, diabetes, type I diabetes and type II diabetes.

traducir

SWALLOWABLE CAPSULE, SYSTEM AND METHOD FOR MEASURING GASTRIC EMPTYING PARAMETERS

Publication No.: US2022008013A1 13/01/2022

Applicant:

RANI THERAPEUTICS LLC [US]

JP_2020523123_A

Absstract of: US2022008013A1

Embodiments provide devices, systems and methods for measuring a gastric emptying (GE) parameter (GEP). Many embodiments provide a swallowable capsule having three electrodes one covered by a coating which remains in the stomach but is degraded in the small intestine (SI). The electrodes are coupled to circuitry such that when the capsule is in the stomach, current flow occurs between the first two electrodes generating a first signal and in the SI current flow occurs between the second and now uncovered third electrode generating a second signal. These two signals can be transmitted and analyzed externally or by an internal controller to determine a GEP e.g., GE time. The patient may wear an external device configured to receive and analyze the signals to determine GE time. Embodiments of the invention may be used to diagnose gastroparesis and provide patient's information on when to eat meals or administer insulin after eating.

traducir

Catheter Assembly Including Monitoring Capabilities

Publication No.: US2022008012A1 13/01/2022

Applicant:

BARD INC C R [US]

CN_113598720_A

Absstract of: US2022008012A1

A catheter assembly or other elongate tubular device for use in establishing vascular or other access within the body of a patient is disclosed. The catheter assembly is equipped with one or more sensors that enable monitoring of one or more physiological aspects of the patient or physical aspect of the catheter assembly itself when the catheter assembly is disposed within the patient. Such aspects include central venous pressure, body temperature, ECG heart signals, oxygen levels, ultrasound data, glucose, etc. The catheter assembly includes the ability to wirelessly transmit or otherwise forward data relating to the detected physiological parameters to another location, such as a patient electronic medical record, smartphone or other mobile device, nurse station, etc. Catheter assemblies configured to detect the frequency of catheter flushing, flushing quality, etc., are also disclosed.

traducir

REAL TIME MANAGEMENT OF DATA RELATING TO PHYSIOLOGICAL CONTROL OF GLUCOSE LEVELS

Publication No.: EP3936032A1 12/01/2022

Applicant:

ABBOTT DIABETES CARE INC [US]

US_2021200787_A1

Absstract of: WO2011011739A2

Continuous glucose monitoring (CGM) data and insulin delivery data are used to generate more reliable projected alarms related to a projected glucose levels. A memory stores endogenous data related to measurements of glucose level in a patient, and also stores exogenous data, such as insulin on board, both of which are used by a processor to create projected alarms. Profiles of CGM data are created for use in tuning patient-specific insulin data, such at basal rate, carb ratio, and insulin sensitivity. A processor searches for patterns in the data profiles and if found, recommended changes to patient-specific insulin data are provided to permit more accurate control over a patient's glucose levels.

traducir

Indirect bio-feedback health and fitness management system

Publication No.: US11222730B1 11/01/2022

Applicant:

LAVI NATAN [US]
ARIELY DAN [US]

Absstract of: US11222730B1

A health and fitness management system utilizing an algorithm to suggest actions to improve a user's health and fitness. The system obtains a user's health indicating measurement from a respective acquisition device. The user is never informed of the acquired data. The health indicating measurement can include a heart/pulse rate, blood pressure measurement, weight, blood sugar level, etc. Base line data (age, ideal age, initial weight, current weight, ideal weight, etc.) can be considered in the algorithm. Examples include the user's environment, sleep habits, exercise routines, medical records, and the like. The health index number is used to determine recommended actions, which can include changes to environments, routines, activities, etc. Data collection, the algorithm, and other features of the system can be provided by an Application operating on a portable computing device. Features of the portable computing device can be employed to automatically acquire data for the algorithm.

traducir

INFUSION PUMP SYSTEMS AND METHODS

Publication No.: US2022001106A1 06/01/2022

Applicant:

TANDEM DIABETES CARE INC [US]

US_2020016335_A1

Absstract of: US2022001106A1

Embodiments are directed to portable infusion devices, systems, and methods of using the same for dispensing materials. In some cases, the devices, systems and methods may be used for infusing a material such as medicament, e.g., insulin, into a body in need thereof.

traducir

SYSTEMS AND METHODS FOR HEALTH DATA VISUALIZATION AND USER SUPPORT TOOLS FOR CONTINUOUS GLUCOSE MONITORING

Publication No.: US2022000432A1 06/01/2022

Applicant:

DEXCOM INC [US]

JP_2021184842_A

Absstract of: US2022000432A1

Disclosed are systems and methods for generating graphical displays of analyte data and/or health information. In some implementations, the graphical displays are generating based on a self-referential dataset that are modifiable based on identified portions of the data. The modified graphical displays can indicate features in the analyte data of a host.

traducir

METHOD FOR PROVIDING RECOMMENDATIONS FOR MAINTAINING A HEALTHY LIFESTYLE BASING ON DAILY ACTIVITY PARAMETERS OF USER, AUTOMATICALLY TRACKED IN REAL TIME, AND CORRESPONDING SYSTEM

Publication No.: US2022005580A1 06/01/2022

Applicant:

SAMSUNG ELECTRONICS CO LTD [KR]

WO_2020111787_A1

Absstract of: US2022005580A1

According to a first aspect of the present invention, there is provided a method for providing recommendations for maintaining a healthy lifestyle basing on user's daily activity parameters automatically tracked in real time, comprising the steps of: measuring automatically the user's daily activity parameters, including periods of physical activity, changes in blood glucose level, and data of a food intake; building a physiological model basing on the measured change in the user's blood glucose level to determine an individual response of the user to food intake; training a machine learning algorithm to estimate the user's daily activity basing on the measured parameters of the user's daily activity, the determined individual response of the user and a predefined user profile containing the user's gender, age, height and weight; generating recommendations for maintaining of the user's healthy lifestyle basing on estimation of the unser's daily activity received as a result of using the machine learning algorithm; and displaying generated recommendations to the user.

traducir

THERMALLY STABLE GLUCOSE LIMITING MEMBRANE FOR GLUCOSE SENSORS

Publication No.: US2022000401A1 06/01/2022

Applicant:

MEDTRONIC MINIMED INC [US]

US_2018325436_PA

Absstract of: US2022000401A1

Embodiments of the invention provide compositions useful in analyte sensors as well as methods for making and using such compositions and sensors. In typical embodiments of the invention, the sensor is a glucose sensor comprising an analyte modulating membrane formed from a polymeric reaction mixture formed to include limiting amounts of catalyst and/or polycarbonate compounds so as to provide such membranes with improved material properties such as enhanced thermal and hydrolytic stability.

traducir

A patient worn Solar fabric hospital clothing and apparatus capable of identifying the health parameters.

Publication No.: AU2021107275A4 06/01/2022

Applicant:

CHOITHRANI RENU

Absstract of: AU2021107275A4

A patient worn Solar fabric hospital clothing and apparatus capable of identifying the health parameters. The invention describes a patient wearable gown that is made from solar fabric which is capable of generating energy using Photovoltaic cells equipped on the same and it is capable of powering every sensor in the gown which is equipped to detect the parameters of the patient. It is equipped with multiple sensors to track and monitor the health of the patient along with provide real time analysis of the body parameters non-invasively. To keep all the sensors charged the gown is made with solar fabric and thermoelectric components to generate electric power to charge the sensors. The gown provides continuous tracking of the health parameters including the fluid in the lungs using nano sensors capable of identifying if there is any fluid in the lungs or heart making it the patient difficult to breathe. It has a mechanism to control alarm systems and to immediately call emergency services in case the person is not already hospitalized. The gown can identify the routine, the pulse, the blood flow, the body glucose level, body oxygen level non invasively. The gown along with being portable is capable of being adjusted to a person of varying sizes with the used of the adjustable mechanism attached to the gown. Signatory Dr. Renu Choithrani Page 1 of 6 Dr. Renu Choithrani SRWk MEA$!tG PULSE RATE, BRODY EMRTURE, R AND ACCEERA2 RECOGNQE POSTURE AND ACT& FAACCELRATION ACQUIRECURRENT

traducir

SYSTEMS, DEVICES, AND METHODS FOR MEAL INFORMATION COLLECTION, MEAL ASSESSMENT, AND ANALYTE DATA CORRELATION

Publication No.: US2022000399A1 06/01/2022

Applicant:

ABBOTT DIABETES CARE INC [US]

Absstract of: US2022000399A1

Systems, devices, and methods for detecting, measuring and classifying meals for an individual based on analyte measurements. These results and related information can be presented to the individual to show the individual which meals are causing the most severe analyte response. These results can be organized and categorized based on preselected criteria or previous meals and results so as to organize and present the results in a format with reference to glucose as the monitored analyte. Various embodiments disclosed herein relate to methods, systems, and software applications intended to engage an individual by providing direct and timely feedback regarding the individual's meal-related glycemic response.

traducir

THERMOMETER DEVICE

Publication No.: US2022003614A1 06/01/2022

Applicant:

JACKSON STATE UNIV [US]

Absstract of: US2022003614A1

A device for measuring the temperature of a lower extremity of a subject in need of such monitoring. The device is especially suited for monitoring the foot temperature of a subject with diabetes or another condition that could lead to lower blood circulation and temperature in the lower extremities of the subject. Methods of preventing complications from such diseases, disorders, syndromes, or conditions are provided. The past recorded temperatures of the subject may be stored for comparisons and trends analyses.

traducir

METHOD FOR CALIBRATING BLOOD GLUCOSE VALUE IN CONTINUOUS BLOOD GLUCOSE MEASUREMENT SYSTEM

Publication No.: EP3932310A1 05/01/2022

Applicant:

I SENS INC [KR]

AU_2020393447_A1

Absstract of: WO2021107335A1

The present invention relates to a method for calibrating a blood glucose value in a continuous blood glucose measurement system. More particularly, blood glucose values can be accurately calibrated according to a calibration mode by differently selecting calibration modes for calibrating blood glucose values on the basis of whether the difference between a blood glucose value measured by a continuous blood glucose measurement system and a reference blood glucose value measured by a separate blood glucose meter is outside a set range. In addition, the blood glucose value of a user can be accurately calibrated by activating, to be scrolled on an input window, only the ranges of the blood glucose value and a reference blood glucose value calculated on the basis of a preset critical range, or by forcibly or automatically calibrating the blood glucose value by a second calibration mode which uses multiple reference blood glucose values, when a reference blood glucose value outside the reference blood glucose value range is input.

traducir

BODY ATTACHMENT DEVICE FOR CONTINUOUS GLUCOSE MONITORING

Publication No.: EP3932308A1 05/01/2022

Applicant:

I SENS INC [KR]

AU_2020386264_A1

Absstract of: WO2021101022A1

The present invention relates to a body attachment device for continuous glucose monitoring and, more particularly, to a body attachment device for continuous glucose monitoring characterized in that as a user command for applying operating power of the body attachment device is inputted by an optical method or a touch method, operation of the body attachment device can be controlled by easily initiating application of battery power not only before the body attachment device is attached to the body but also after the body attachment device has been attached to the body. In addition, as the operation of the body attachment device is controlled by light or touch, it is possible to prevent erroneous operation of the body attachment device that occurs when a user touches, by mistake, a physical operation button formed in the body attachment device while using the body attachment device. Furthermore, the operating power can be stably provided.

traducir

SYSTEMS AND METHODS FOR ANALYZING, INTERPRETING, AND ACTING ON CONTINUOUS GLUCOSE MONITORING DATA

Publication No.: US2021401333A1 30/12/2021

Applicant:

WELLDOC INC [US]

US_2021290112_A1

Absstract of: US2021401333A1

Methods and devices include automated coaching for management of glucose states by receiving a user's glucose levels using a continuous glucose monitoring (CGM) device, determining a time in range (TIR) value, determining a TIR state, receiving a glucose variability (GV) value, determining a GV state, determining a starting state based on the TIR state and the GV state, determining that the starting state corresponds to a non-ideal state, generating an optimized pathway to reach an ideal state based on one or more account vectors such as addressing self-management behavior including food, activity, and medication use. The optimized pathway may further be based on computer detection and classification of significant events of interest over time.

traducir

ALARMS AND ALERTS FOR MEDICATION DELIVERY DEVICES AND SYSTEMS

Publication No.: US2021401367A1 30/12/2021

Applicant:

BIGFOOT BIOMEDICAL INC [US]

US_2019274624_A1

Absstract of: US2021401367A1

Systems, methods, and devices provide alarms and alerts in an on-body networked diabetes management system. Methods may include receiving glucose sensor data from a continuous glucose monitor and determining a dosage of insulin delivery based at least in part on the glucose sensor data. The method may include detecting an alarm or alert condition, and sending a wireless communication regarding the alarm or alert condition to a remote user-interface device. The method may include triggering an audible, visual, or haptic alarm or alert on the insulin delivery device unless an acknowledgement of the alarm or alert condition is received within a predetermined period of time.

traducir

DIABETES PREDICTION USING GLUCOSE MEASUREMENTS AND MACHINE LEARNING

Publication No.: US2021401330A1 30/12/2021

Applicant:

DEXCOM INC [US]

Absstract of: US2021401330A1

Diabetes prediction using glucose measurements and machine learning is described. In one or more implementations, the observation analysis platform includes a machine learning model trained using historical glucose measurements and historical outcome data of a user population to predict a diabetes classification for an individual user. The historical glucose measurements of the user population may be provided by glucose monitoring devices worn by users of the user population, while the historical outcome data includes one or more diagnostic measurements obtained from sources independent of the glucose monitoring devices. Once trained, the machine learning model predicts a diabetes classification for a user based on glucose measurements collected by a wearable glucose monitoring device during an observation period spanning multiple days. The predicted diabetes classification may then be output, such as by generating one or more notifications or user interfaces based on the classification.

traducir

SELF-MONITORING AND CARE ASSISTANT FOR ACHIEVING GLYCEMIC GOALS

Publication No.: US2021401332A1 30/12/2021

Applicant:

MY VITALITY SARL [CH]

CA_3119887_PA

Absstract of: US2021401332A1

A device, a system for the device and a set of methods used to extract pulse wave features and select an optimal combination of these features for calculating and determining the blood glucose level and discriminating between different sources of blood glucose level changes in a subject, wherein the different blood glucose level changes are selected among the type of nutrients, sport activities, stresses and fatigue or a combination thereof. The system is designed for accurately obtaining, measuring, registering and interpreting the pulse to determine the blood glucose level of a subject. By collecting pulse wave features, selecting those that are most significant and developing algorithms, the device and its method calculates the user's blood glucose levels and discriminates between different sources of blood glucose level changes of the subject.

traducir

Glucose Monitoring Smart Watch

Publication No.: US2021401331A1 30/12/2021

Applicant:

FLORES BELINDA [US]

Absstract of: US2021401331A1

The Diabetic Glucose Monitoring Smart Watch, in conjunction with the “Save a Life, Link a Buddy” smart phone application, is designed for any person with Type I or Type II Diabetes. The smart watch will monitor the blood glucose levels of the wearer through a continuous glucose monitor and will alert the user in real-time if glucose levels reach a danger zone designated by the user during set up. If the wearer is unresponsive to the alert for over 60 seconds, the linked application (“Save a Life, Link a Buddy) will then notify the “buddies” assigned by the user. This alert will appear on the “buddies” phone similar to an Amber-Alert that needs to be turned off manually.

traducir

AUTOMATIC DETECTION OF UN-BOLUSED MEALS

Publication No.: US2021402091A1 30/12/2021

Applicant:

TANDEM DIABETES CARE INC [US]

US_2019365997_PA

Absstract of: US2021402091A1

Missed meal bolus reminders or alerts require a user to access the user's pump and/or remote control to clear the reminder/alert even when the user skipped a meal such that no meal bolus was needed. CGM data can be leveraged such that the missed meal bolus alert is only triggered when glucose levels rise in response to consuming the meal within the programmed time window. Therefore, the alert is only provided when a meal is actually consumed and no bolus has been delivered. This further allows the user to be alerted sooner, i.e., as soon as glucose levels rise a predetermined amount or passed a predetermined threshold indicating consumption of a meal as opposed to only at the end of the programmed window.

traducir

CONTINUOUS GLUCOSE MONITORING INJECTION DEVICE

Publication No.: US2021402092A1 30/12/2021

Applicant:

BECTON DICKINSON CO [US]

US_2019298920_PA

Absstract of: US2021402092A1

An electronic insulin delivery device receives glucose data from a glucose monitor and sets a bolus dose amount. The device may take the form of an insulin pen with automatic priming and accurate dosing provided by a motor in connection with an encoder. The device may communicate with and be controlled by a smart phone device. The smart phone device provides a user interface to receive user data including patient weight, insulin to carbohydrate ratio and exercise factor, and to send instructions to the device, including dose amount. The dose amount is determined taking into account glucose level and trend, and other factors. The delivery device may be in continuous communication with the glucose monitor and smart phone to provide for near real-time adjustments in glucose treatment. Glucose data, insulin injection data, and other relevant data may be stored and accessible to interested parties.

traducir

Artificial Pancreas Integrated CGM Architectures and Designs

Publication No.: US2021402093A1 30/12/2021

Applicant:

ABBOTT DIABETES CARE INC [US]

WO_2019005686_A1

Absstract of: US2021402093A1

A system for managing a patient's glucose level includes a glucose sensor to generate and store data signals for measurements of the patient's glucose level made by the glucose sensor; an insulin pump; and sensor electronics operatively coupled to the glucose sensor, the sensor electronics comprising a memory storing one or more predetermined characteristics associated with the sensor electronics; and a computing device in electronic communication with the sensor electronics. The computing device comprises a processor configured to operate the sensor electronics to (i) receive the generated data signals, (ii) obtain the one or more predetermined sensor characteristics from the memory and (iii) execute a closed-loop algorithm to provide insulin delivery instructions to an insulin pump by at least using the data signals and predetermined characteristics.

traducir

BLOOD GLUCOSE CONTROL SYSTEM WITH REAL-TIME GLYCEMIC CONTROL OPTIMIZATION

Nº publicación: US2021402090A1 30/12/2021

Applicant:

BETA BIONICS INC [US]

US_2021299352_A1

Absstract of: US2021402090A1

A blood glucose control system is configured to modify therapy provide to a subject and determine whether the modified therapy results in a statistically significant improvement in glycemic control. The system obtains glycemic control information resulting from delivery of first therapy using a first value of a control parameter and determines a first effect corresponding to the first therapy. The control parameter is set to a second value that differs from the first value. The system obtains glycemic control information resulting from the delivery of the second therapy using the second value of the control parameter and determines a second effect corresponding to the second therapy. The system can perform a comparative assessment and determine whether the second value for the control parameter results in a statistically significant improvement in glycemic control for the subject.

traducir

Page1/6 nextPage results/page

punteroimgGo back